(NASDAQ: ACOG) Alpha Cognition's forecast annual revenue growth rate of 90.77% is forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 34.63%, and it is also forecast to beat the US market's average forecast revenue growth rate of 13.72%.
Alpha Cognition's revenue in 2026 is $10,825,419.On average, 7 Wall Street analysts forecast ACOG's revenue for 2026 to be $490,461,693, with the lowest ACOG revenue forecast at $397,508,043, and the highest ACOG revenue forecast at $589,708,059. On average, 7 Wall Street analysts forecast ACOG's revenue for 2027 to be $1,078,406,049, with the lowest ACOG revenue forecast at $751,402,555, and the highest ACOG revenue forecast at $1,369,482,271.
In 2028, ACOG is forecast to generate $1,628,289,271 in revenue, with the lowest revenue forecast at $1,125,917,144 and the highest revenue forecast at $2,085,088,199.